Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study

OBJECTIVE: To monitor the adverse drug reactions (ADRs) associated with imatinib treatment in patients with chronic myeloid leukemia (CML) in a tertiary care hospital. MATERIALS AND METHODS: The study was carried out by the Departments of Pharmacology and Medical Oncology, Jawaharlal Institute of Po...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Jose, Palaniappan, Muthiah, Dubashi, Biswajit, Pradhan, Suresh Chandra, Chandrasekaran, Adithan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319245/
https://www.ncbi.nlm.nih.gov/pubmed/25709349
http://dx.doi.org/10.4103/0976-500X.149141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319245/
https://www.ncbi.nlm.nih.gov/pubmed/25709349
http://dx.doi.org/10.4103/0976-500X.149141

Ejemplares similares